Mozzarc, after reading many posts here I have sat back, watched and not commented. I currently hold 140,000 shares and am happy with my holding. However, after reading all posts, this is my observation. PAR today are fully funded, thanks to the generosity of the shareholders at the last CR in April of this year to take IPPS to commercialisation! Paul Rennie is no fool as he and his team know what they have discovered. Their IMO is no point whatsoever in taking a Big Pharma deal whilst we continue to release real world Meaningful Data. I myself believe that Paul Rennie would compare selling PAR to selling a child, he doesn't need the money! I believe PAR will be taken to commercialisation then he may make a deal that represents true value for the company and its shareholders
PAR Price at posting:
$1.95 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)